Nedocromil
Mast Cell Stabilizer — RESPIRATORY SYSTEM
Also known as: nedocromil sodium
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Nedocromil is an ofm drug in the Mast Cell Stabilizer class catalogued in DrugCentral. It was first approved by the FDA in 1992. DrugCentral lists 2 molecular targets, including GPR35 and CYSLTR1. Recorded indications include Allergic conjunctivitis, Asthma, Asthma management and Ocular Itching.
- Approval status: ofm (first approved 1992 by the FDA).
- Drug class: Mast Cell Stabilizer.
- Molecular targets: GPR35 and CYSLTR1 (2 listed in DrugCentral).
- Indications: Allergic conjunctivitis, Asthma, Asthma management and Ocular Itching.
- ATC code: R01AC07 (Antiallergic agents, excl. corticosteroids).
- Molecular formula: C19H17NO7; molecular weight 371.35 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (4)
- Allergic conjunctivitis
- Asthma
- Asthma management
- Ocular Itching
Off-label uses (1)
- Bronchospasm Prevention
Mechanism & targets
| Established pharmacologic class | Mast Cell Stabilizer |
|---|
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| G-protein coupled receptor 35 | GPR35 | agonist | EC50 6.01 |
| Cysteinyl leukotriene receptor 1 | CYSLTR1 | unknown | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1992-12-30 | FDA | — | KING PHARMS |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R01AC07 | RESPIRATORY SYSTEM › NASAL PREPARATIONS › DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE › Antiallergic agents, excl. corticosteroids |
R03BC03 | RESPIRATORY SYSTEM › DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES › OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS › Antiallergic agents, excl. corticosteroids |
S01GX04 | SENSORY ORGANS › OPHTHALMOLOGICALS › DECONGESTANTS AND ANTIALLERGICS › Other antiallergics |
Chemical structure
| Molecular formula | C19H17NO7 |
|---|---|
| Molecular weight | 371.35 g/mol |
| CAS number | 69049-73-6 |
| InChIKey | RQTOOFIXOKYGAN-UHFFFAOYSA-N |
| PubChem CID | 50294 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Nedocromil used for?
DrugCentral lists the following indications for Nedocromil: Allergic conjunctivitis, Asthma, Asthma management and Ocular Itching.
How does Nedocromil work?
Its molecular targets in DrugCentral include GPR35 (agonist) and CYSLTR1.
When was Nedocromil first approved?
Nedocromil was first approved by the FDA in 1992.
What drug class does Nedocromil belong to?
Nedocromil is in the Mast Cell Stabilizer class.
What is the chemical formula of Nedocromil?
Nedocromil has the molecular formula C19H17NO7 and a molecular weight of 371.35 g/mol.
Browse: all drugs starting with N · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1889 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL746 — compound record and bioactivity
- PubChem CID 50294 — chemical identifiers
- DrugBank DB00716 — drug record
- FDA UNII 0B535E0BN0 — substance identity
- DailyMed: FDA labels for Nedocromil — current prescribing information (label search)
- UniProt Q9HC97 (GPR35) — target protein
- UniProt Q9Y271 (CYSLTR1) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.